Antileishmanial activity of antimonials entrapped in liposomes.

作者信息

New R R, Chance M L, Thomas S C, Peters W

出版信息

Nature. 1978 Mar 2;272(5648):55-6. doi: 10.1038/272055a0.

DOI:10.1038/272055a0

PMID:203863

Abstract

摘要

相似文献

Antileishmanial activity of antimonials entrapped in liposomes.

Nature. 1978 Mar 2;272(5648):55-6. doi: 10.1038/272055a0.

Treatment of visceral leishmaniasis using sodium stibogluconate in a dose of 15 mg antimony/kg body weight twice daily for 30 days: a preliminary report.

East Afr Med J. 1984 Jul;61(7):570-4.

Vesicular systems (niosomes and liposomes) for delivery of sodium stibogluconate in experimental murine visceral leishmaniasis.

J Pharm Pharmacol. 1988 Mar;40(3):161-5. doi: 10.1111/j.2042-7158.1988.tb05210.x.

The use of Pentostam liposomes in the chemotherapy of experimental leishmaniasis.

Trans R Soc Trop Med Hyg. 1977;71(6):550-2. doi: 10.1016/0035-9203(77)90155-9.

Drug targeting in Leishmania donovani infections using tuftsin-bearing liposomes as drug vehicles.

FEBS Lett. 1989 Mar 13;245(1-2):204-8. doi: 10.1016/0014-5793(89)80222-4.

Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs.

Proc Natl Acad Sci U S A. 1978 Jun;75(6):2959-63. doi: 10.1073/pnas.75.6.2959.

Biodegradable microspheres: polyacryl starch microparticles as a delivery system for the antileishmanial drug, sodium stibogluconate.

J Pharm Pharmacol. 1987 Oct;39(10):832-5. doi: 10.1111/j.2042-7158.1987.tb05126.x.

Non-ionic surfactant vesicles, niosomes, as a delivery system for the anti-leishmanial drug, sodium stibogluconate.

J Pharm Pharmacol. 1986 Jul;38(7):502-5. doi: 10.1111/j.2042-7158.1986.tb04623.x.

Treatment of visceral leishmaniasis.

J Assoc Physicians India. 1985 May;33(5):379-80.

[Treatment of visceral leishmaniasis in patients with antimonials: is there a maximal dose?].

An Med Interna. 1999 Nov;16(11):602.

引用本文的文献

Progress in antileishmanial drugs: Mechanisms, challenges, and prospects.

PLoS Negl Trop Dis. 2025 Jan 3;19(1):e0012735. doi: 10.1371/journal.pntd.0012735. eCollection 2025 Jan.

Antisense Therapy for Infectious Diseases.

Cells. 2023 Aug 21;12(16):2119. doi: 10.3390/cells12162119.

Robotics, microfluidics, nanotechnology and AI in the synthesis and evaluation of liposomes and polymeric drug delivery systems.

Drug Deliv Transl Res. 2021 Apr;11(2):345-352. doi: 10.1007/s13346-021-00929-2. Epub 2021 Feb 13.

Nanostructured delivery systems with improved leishmanicidal activity: a critical review.

Int J Nanomedicine. 2017 Jul 26;12:5289-5311. doi: 10.2147/IJN.S140363. eCollection 2017.

Nanoliposomal artemisinin for the treatment of murine visceral leishmaniasis.

Int J Nanomedicine. 2017 Mar 20;12:2189-2204. doi: 10.2147/IJN.S106548. eCollection 2017.

Cationic liposomal sodium stibogluconate (SSG), a potent therapeutic tool for treatment of infection by SSG-sensitive and -resistant Leishmania donovani.

Antimicrob Agents Chemother. 2015 Jan;59(1):344-55. doi: 10.1128/AAC.03305-14. Epub 2014 Nov 3.

Association of liposome-encapsulated trivalent antimonial with ascorbic acid: an effective and safe strategy in the treatment of experimental visceral leishmaniasis.

PLoS One. 2014 Aug 8;9(8):e104055. doi: 10.1371/journal.pone.0104055. eCollection 2014.

Liposome: classification, preparation, and applications.

Nanoscale Res Lett. 2013 Feb 22;8(1):102. doi: 10.1186/1556-276X-8-102.

Therapy with sodium stibogluconate in stearylamine-bearing liposomes confers cure against SSG-resistant Leishmania donovani in BALB/c mice.

PLoS One. 2011 Mar 10;6(3):e17376. doi: 10.1371/journal.pone.0017376.

Pentavalent antimonials: new perspectives for old drugs.

Molecules. 2009 Jun 30;14(7):2317-36. doi: 10.3390/molecules14072317.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验